Lenvatinib

Fatigue: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Iwamoto H, et al. Weekends-off lenvatinib for unresectable hepatocellular carcinoma improves therapeutic response and tolerability toward adverse events. Cancers 12: 1010, No. 4, Apr 2020. Available from: URL: http://doi.org/10.3390/cancers12041010

      Article  Google Scholar 

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Lenvatinib. Reactions Weekly 1806, 174 (2020). https://doi.org/10.1007/s40278-020-79192-0

    Download citation